USPTO serial 88163086
QUICKSTRIP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOOK, JEFFREY J
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with QUICKSTRIP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Burlington, Ontario, CA
Burlington, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
TODD A VAN THOME
TODD A VAN THOME NYEMASTER GOODE, PC700 WALNUT STREET SUITE 1600DES MOINES, IA 50309UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Consulting in the field of orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the field of orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well being, nicotine and nicotine-polymer complexes; consulting in the field of orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the field of orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the field of orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diptheria, typhoid, meningitis, multiple schlerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2021 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Aug 6, 2021 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 6, 2021 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| May 3, 2021 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 18, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 14, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 29, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 18, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2019 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Nov 7, 2019 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Sep 5, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 26, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 1, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |